AWARDDEFINITIVE CONTRACTSmall business
Definitive contract HHSN268201400006CVASCULAR BIOSCIENCES
Overview
Award facts
- Net obligations
- $1.15M
- $1,149,127of $1.15M potential value
- Period of performance
- Nov 15, 2013 to Nov 14, 2016
- Ended
- Modifications
- 4
- Latest action Apr 13, 2020
- Contract type
- Definitive contract
- PIID HHSN268201400006C
Description of requirement
IGF::OT::IGF VASCULAR INTERVENTIONS/INNOVATIONS AND THERAPEUTIC ADVANCES (VITA): CAR PEPTIDE THERAPEUTIC ADJUVANT FOR PAH TARGETED THERAPY
Dates and value
- Award date
- Signed on Nov 15, 2013
- Potential end of performance
- Nov 13, 2016
- Current value
- $1,149,127Base and exercised options
- Potential value (if all options are exercised)
- $1,149,127
Obligations by fiscal year of action
- FY2016: $385,534
- FY2015: $401,635
- FY2014: $361,958
Total across 3 fiscal years: $1,149,127
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Apr 13, 2020. View on USAspending · Recipient on SAM.gov
Recipient
LocationDURHAM, NC
UEIETJLM26WRKP5
CAGE code3YCF8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyVASCULAR BIOSCIENCES
Business types and certifications
Self-certified small disadvantaged businessLabor surplus area firm (Department of Labor)For-profit organizationCorporation (not tax-exempt)Manufacturer of goods
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
Place of performance
- Place of performance
- Durham, North Carolina 27703-5420
- Congressional district (place of performance)
- NC-04As reported at the time of the action
Classification and competition
Classification
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 31
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Igf::ot::igf vascular interventions/innovations and therapeutic advances (VITA): car peptide therape
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Nov 15, 2013Base obligation at award: $361,958
- Latest action
- Apr 13, 2020 — CloseoutModification P00004; administrative: no change in scope or value
- Latest substantive action
- Nov 13, 2015 — Option exercisedModification 3; obligation change +$385,534
- Actions by type
- Base award1
- Option exercised2
- Closeout1
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Closely associatedCL
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N920
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N920